Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Abbott Laboratories

Abbott Laboratories (ABT.SW) Stock Overview

Explore Abbott Laboratories’s financial performance, market position, analyst ratings, and future outlook.

ABT.SW●SIX
HealthcareMedical - Devices
CHF72.50
CHF2.00(2.68%)
Swiss Market opens in 17h 12m

Abbott Laboratories (ABT.SW)

Meyka AI Score

Z

Key Financials

Market Cap125.5B
P/E Ratio28.76
EPS (TTM)$3.66
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$69.66
3 Months$106.89
1 Year Target$84.70

ABT.SW Stock Analysis & Investment Overview (SIX)

Our AI-powered analysis of Abbott Laboratories (SIX: ABT.SW) gives investors deep insight into how the stock performs on the SIX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Abbott Laboratories's SIX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ABT.SW on the SIX shows an RSI of 77.12, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $84.70 for the SIX listing.

Key metrics behind Abbott Laboratories's SIX-traded stock include a P/E ratio of 28.76 and a market capitalization of 125.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ABT.SW on the SIX.

Price Performance (SIX: ABT.SW)

1-Day Change
N/A
5-Day Change
-6.45%
1-Month Change
2.11%
3-Month Change
11.54%
6-Month Change
-27.50%
Year-to-Date (YTD) Change
-26.77%
1-Year Change
-31.60%
3-Year Change
-20.77%
5-Year Change
-26.02%
All-Time (Max) Change
117.39%

Contact Information

https://www.abbott.com
224 667 6100
100 Abbott Park Road, North Chicago, IL, 60064-6400

Company Facts

1,140,000 Employees
IPO DateJul 17, 1998
CountryUS

Frequently Asked Questions